Skip to main navigation Skip to search Skip to main content

An Open-label, Single Arm Phase II Study of RAD001 in Patients with Refractory Mantle Cell Lymphoma

Upstate Medical University

Project: Research

Project Details

StatusFinished
Effective start/end date05/6/09 → 04/5/11

Funding

  • Novartis Pharmaceuticals Corporation: $11,000.00